• 1Nong Jiu Shi Hospital, Xinjiang Army, Emin Xinjiang 834601; 2 Department of Neurology, Jiangyou People’s Hospital, Jiangyou Sichuan 621700; 3Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China;
Export PDF Favorites Scan Get Citation

目的:探討普羅布考對動脈粥樣硬化性腦梗死并高脂血癥患者血脂及預后的影響。方法:將87例腦梗死并高脂血癥患者隨機分為兩組,治療組44例,對照組43例,兩組除按動脈粥樣硬化性腦梗死常規治療外,停用一切降脂藥物。治療組給予普羅布考500mg bid/d。療程為6個月。隨訪一年觀察兩組患者治療后血脂水平及腦血管事件發生情況。結果:治療組患者治療前、后總膽固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)間差異均有顯著性意義(P lt;0.05)。兩組患者治療后各項血脂指標間差異均有顯著性意義(P lt;0.05)。隨訪一年,顯示治療組患者心腦血管事件14次,對照組19次(P lt;0.05)。結論:普羅布考降脂療效可靠、副作用輕微,降低心腦血管事件發生。可作為動脈粥樣硬化性腦梗死并高脂血癥患者的一、二級預防藥物。

Citation: XIAO Weijun,ZHANG Hao,XU Pingrong.. Clinical Investigation on Treating Arteriosclerotic Cerebral Infarction Combined with Hyperlipemia by Prubucol. West China Medical Journal, 2009, 24(9): 2234-2236. doi: Copy

Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved